117 results
6-K
EX-99.3
BLRX
Bioline Rx Ltd
28 May 24
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate
7:11am
expenses for both periods primarily relate to interest paid on loans, partially offset by investment income earned on our bank deposits.
Liquidity
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
to $3.2 million as of December 31, 2023. We have a full right of offset for amounts payable to the IIA for motixafortide from payments that we may owe … from such funding. However, if we become legally required to make payments to the IIA in respect of grants made to Biokine, we have the right to offset
6-K
EX-99
BLRX
Bioline Rx Ltd
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
of warrant liabilities on our balance sheet, offset by warrant offering expenses.
Financial income (expenses), net
Three months ended September 30 … of the US dollar during the period, offset by investment income earned on our bank deposits.
Comparison of nine-month periods ending September 30, 2023
6-K
EX-99
BLRX
Bioline Rx Ltd
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
related to pre-commercialization and commercialization activities, which were partially offset by a decrease in research and development expenses
6-K
EX-99
1z59e
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
EX-99
r87zoj2e2ebce
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
ygnp2xr0kg07jr
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-99
5l6t 2siv8
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am
6-K
EX-99
hhdga5hxqju u0d
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am
6-K
EX-99
gvmzltj1
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
mddwpnb1
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
hqcomjnpw4gav4748fua
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
9dgpj 5g28dqhxfb2j4n
11 May 22
BioLineRx Reports First Quarter 2022 Financial Results
7:14am
6-K
EX-99
c48lgl1q
11 May 22
BioLineRx Reports First Quarter 2022 Financial Results
7:14am
6-K
EX-99
s6yx27
16 Mar 22
BioLineRx Reports Fourth Quarter 2021 Financial Results
7:11am
6-K
EX-99
atjwbf67o4ytp
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
s0mk6
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
8gb 6qnx8
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am